Daniel Rayson1. Show Affiliations » 1. From Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada daniel.rayson@nshealth.ca.
Abstract
Mesh： See more » Adaptation, PsychologicalAgedAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAttitude to DeathBone Neoplasms/drug therapyBone Neoplasms/psychologyBone Neoplasms/secondaryBreast Neoplasms/drug therapyBreast Neoplasms/pathologyBreast Neoplasms/psychologyDiphosphonates/administration & dosageDiphosphonates/adverse effectsDisease ProgressionFemaleHumansInfusions, IntravenousNurse-Patient RelationsPamidronateQuality of LifeTreatment Outcome
Substances： See more » Antineoplastic AgentsDiphosphonatesPamidronate
Year: 2016 PMID： 26884561 DOI： 10.1200/JCO.2015.65.8419
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544